866-997-4948(US-Canada Toll Free)

Global Oral Antidiabetic Drugs Market Professional Survey Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 117 Pages

This report studies Oral Antidiabetic Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Eli Lilly
Abbott
Biocon
Sanofi
Merck
Pfizer
Sunpharma
Novartis
Novo Nordisk
Boehringer Ingelheim
Oramed Pharmaceuticals
Takeda Pharmaceuticals
Jiangsu Wanbang
Nanjing Xinbai

By types, the market can be split into
Sulfonylureas
Meglitinides
Biguanides
Alpha-glucosidase Inhibitors
Others

By Application, the market can be split into
Hospitals
Clinics
Others

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Oral Antidiabetic Drugs Market Professional Survey Report 2017
1 Industry Overview of Oral Antidiabetic Drugs
1.1 Definition and Specifications of Oral Antidiabetic Drugs
1.1.1 Definition of Oral Antidiabetic Drugs
1.1.2 Specifications of Oral Antidiabetic Drugs
1.2 Classification of Oral Antidiabetic Drugs
1.2.1 Sulfonylureas
1.2.2 Meglitinides
1.2.3 Biguanides
1.2.4 Alpha-glucosidase Inhibitors
1.2.5 Others
1.3 Applications of Oral Antidiabetic Drugs
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Oral Antidiabetic Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Oral Antidiabetic Drugs
2.3 Manufacturing Process Analysis of Oral Antidiabetic Drugs
2.4 Industry Chain Structure of Oral Antidiabetic Drugs

3 Technical Data and Manufacturing Plants Analysis of Oral Antidiabetic Drugs
3.1 Capacity and Commercial Production Date of Global Oral Antidiabetic Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Oral Antidiabetic Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Oral Antidiabetic Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Oral Antidiabetic Drugs Major Manufacturers in 2016

4 Global Oral Antidiabetic Drugs Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Oral Antidiabetic Drugs Capacity and Growth Rate Analysis
4.2.2 2016 Oral Antidiabetic Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Oral Antidiabetic Drugs Sales and Growth Rate Analysis
4.3.2 2016 Oral Antidiabetic Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Oral Antidiabetic Drugs Sales Price
4.4.2 2016 Oral Antidiabetic Drugs Sales Price Analysis (Company Segment)

5 Oral Antidiabetic Drugs Regional Market Analysis
5.1 North America Oral Antidiabetic Drugs Market Analysis
5.1.1 North America Oral Antidiabetic Drugs Market Overview
5.1.2 North America 2012-2017E Oral Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Oral Antidiabetic Drugs Sales Price Analysis
5.1.4 North America 2016 Oral Antidiabetic Drugs Market Share Analysis
5.2 China Oral Antidiabetic Drugs Market Analysis
5.2.1 China Oral Antidiabetic Drugs Market Overview
5.2.2 China 2012-2017E Oral Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Oral Antidiabetic Drugs Sales Price Analysis
5.2.4 China 2016 Oral Antidiabetic Drugs Market Share Analysis
5.3 Europe Oral Antidiabetic Drugs Market Analysis
5.3.1 Europe Oral Antidiabetic Drugs Market Overview
5.3.2 Europe 2012-2017E Oral Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Oral Antidiabetic Drugs Sales Price Analysis
5.3.4 Europe 2016 Oral Antidiabetic Drugs Market Share Analysis
5.4 Southeast Asia Oral Antidiabetic Drugs Market Analysis
5.4.1 Southeast Asia Oral Antidiabetic Drugs Market Overview
5.4.2 Southeast Asia 2012-2017E Oral Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Oral Antidiabetic Drugs Sales Price Analysis
5.4.4 Southeast Asia 2016 Oral Antidiabetic Drugs Market Share Analysis
5.5 Japan Oral Antidiabetic Drugs Market Analysis
5.5.1 Japan Oral Antidiabetic Drugs Market Overview
5.5.2 Japan 2012-2017E Oral Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Oral Antidiabetic Drugs Sales Price Analysis
5.5.4 Japan 2016 Oral Antidiabetic Drugs Market Share Analysis
5.6 India Oral Antidiabetic Drugs Market Analysis
5.6.1 India Oral Antidiabetic Drugs Market Overview
5.6.2 India 2012-2017E Oral Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Oral Antidiabetic Drugs Sales Price Analysis
5.6.4 India 2016 Oral Antidiabetic Drugs Market Share Analysis

6 Global 2012-2017E Oral Antidiabetic Drugs Segment Market Analysis (by Type)
6.1 Global 2012-2017E Oral Antidiabetic Drugs Sales by Type
6.2 Different Types of Oral Antidiabetic Drugs Product Interview Price Analysis
6.3 Different Types of Oral Antidiabetic Drugs Product Driving Factors Analysis
6.3.1 Sulfonylureas of Oral Antidiabetic Drugs Growth Driving Factor Analysis
6.3.2 Meglitinides of Oral Antidiabetic Drugs Growth Driving Factor Analysis
6.3.3 Biguanides of Oral Antidiabetic Drugs Growth Driving Factor Analysis
6.3.4 Alpha-glucosidase Inhibitors of Oral Antidiabetic Drugs Growth Driving Factor Analysis
6.3.5 Others of Oral Antidiabetic Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Oral Antidiabetic Drugs Segment Market Analysis (by Application)
7.1 Global 2012-2017E Oral Antidiabetic Drugs Consumption by Application
7.2 Different Application of Oral Antidiabetic Drugs Product Interview Price Analysis
7.3 Different Application of Oral Antidiabetic Drugs Product Driving Factors Analysis
7.3.1 Hospitals of Oral Antidiabetic Drugs Growth Driving Factor Analysis
7.3.2 Clinics of Oral Antidiabetic Drugs Growth Driving Factor Analysis
7.3.3 Others of Oral Antidiabetic Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Oral Antidiabetic Drugs
8.1 Eli Lilly
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Eli Lilly 2016 Oral Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Eli Lilly 2016 Oral Antidiabetic Drugs Business Region Distribution Analysis
8.2 Abbott
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Abbott 2016 Oral Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Abbott 2016 Oral Antidiabetic Drugs Business Region Distribution Analysis
8.3 Biocon
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Biocon 2016 Oral Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Biocon 2016 Oral Antidiabetic Drugs Business Region Distribution Analysis
8.4 Sanofi
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Sanofi 2016 Oral Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Sanofi 2016 Oral Antidiabetic Drugs Business Region Distribution Analysis
8.5 Merck
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Merck 2016 Oral Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Merck 2016 Oral Antidiabetic Drugs Business Region Distribution Analysis
8.6 Pfizer
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Pfizer 2016 Oral Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Pfizer 2016 Oral Antidiabetic Drugs Business Region Distribution Analysis
8.7 Sunpharma
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Sunpharma 2016 Oral Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Sunpharma 2016 Oral Antidiabetic Drugs Business Region Distribution Analysis
8.8 Novartis
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Novartis 2016 Oral Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Novartis 2016 Oral Antidiabetic Drugs Business Region Distribution Analysis
8.9 Novo Nordisk
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Novo Nordisk 2016 Oral Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Novo Nordisk 2016 Oral Antidiabetic Drugs Business Region Distribution Analysis
8.10 Boehringer Ingelheim
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Boehringer Ingelheim 2016 Oral Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Boehringer Ingelheim 2016 Oral Antidiabetic Drugs Business Region Distribution Analysis
8.11 Oramed Pharmaceuticals
8.12 Takeda Pharmaceuticals
8.13 Jiangsu Wanbang
8.14 Nanjing Xinbai

9 Development Trend of Analysis of Oral Antidiabetic Drugs Market
9.1 Global Oral Antidiabetic Drugs Market Trend Analysis
9.1.1 Global 2017-2022 Oral Antidiabetic Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Oral Antidiabetic Drugs Sales Price Forecast
9.2 Oral Antidiabetic Drugs Regional Market Trend
9.2.1 North America 2017-2022 Oral Antidiabetic Drugs Consumption Forecast
9.2.2 China 2017-2022 Oral Antidiabetic Drugs Consumption Forecast
9.2.3 Europe 2017-2022 Oral Antidiabetic Drugs Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Oral Antidiabetic Drugs Consumption Forecast
9.2.5 Japan 2017-2022 Oral Antidiabetic Drugs Consumption Forecast
9.2.6 India 2017-2022 Oral Antidiabetic Drugs Consumption Forecast
9.3 Oral Antidiabetic Drugs Market Trend (Product Type)
9.4 Oral Antidiabetic Drugs Market Trend (Application)

10 Oral Antidiabetic Drugs Marketing Type Analysis
10.1 Oral Antidiabetic Drugs Regional Marketing Type Analysis
10.2 Oral Antidiabetic Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Oral Antidiabetic Drugs by Region
10.4 Oral Antidiabetic Drugs Supply Chain Analysis

11 Consumers Analysis of Oral Antidiabetic Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis


12 Conclusion of the Global Oral Antidiabetic Drugs Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures
Figure Picture of Oral Antidiabetic Drugs
Table Product Specifications of Oral Antidiabetic Drugs
Table Classification of Oral Antidiabetic Drugs
Figure Global Production Market Share of Oral Antidiabetic Drugs by Type in 2016
Figure Sulfonylureas Picture
Table Major Manufacturers of Sulfonylureas
Figure Meglitinides Picture
Table Major Manufacturers of Meglitinides
Figure Biguanides Picture
Table Major Manufacturers of Biguanides
Figure Alpha-glucosidase Inhibitors Picture
Table Major Manufacturers of Alpha-glucosidase Inhibitors
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Oral Antidiabetic Drugs
Figure Global Consumption Volume Market Share of Oral Antidiabetic Drugs by Application in 2016
Figure Hospitals Examples
Table Major Consumers in Hospitals
Figure Clinics Examples
Table Major Consumers in Clinics
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Oral Antidiabetic Drugs by Regions
Figure North America Oral Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Figure China Oral Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Figure Europe Oral Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Oral Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Figure Japan Oral Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Figure India Oral Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Table Oral Antidiabetic Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Oral Antidiabetic Drugs in 2016
Figure Manufacturing Process Analysis of Oral Antidiabetic Drugs
Figure Industry Chain Structure of Oral Antidiabetic Drugs
Table Capacity and Commercial Production Date of Global Oral Antidiabetic Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Oral Antidiabetic Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Oral Antidiabetic Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Oral Antidiabetic Drugs Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Oral Antidiabetic Drugs 2012-2017
Figure Global 2012-2017E Oral Antidiabetic Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Oral Antidiabetic Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Oral Antidiabetic Drugs Capacity and Growth Rate
Table 2016 Global Oral Antidiabetic Drugs Capacity (K MT) List (Company Segment)
Table 2012-2017E Global Oral Antidiabetic Drugs Sales (K MT) and Growth Rate
Table 2016 Global Oral Antidiabetic Drugs Sales (K MT) List (Company Segment)
Table 2012-2017E Global Oral Antidiabetic Drugs Sales Price (USD/MT)
Table 2016 Global Oral Antidiabetic Drugs Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Oral Antidiabetic Drugs 2012-2017E
Figure North America 2012-2017E Oral Antidiabetic Drugs Sales Price (USD/MT)
Figure North America 2016 Oral Antidiabetic Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Oral Antidiabetic Drugs 2012-2017E
Figure China 2012-2017E Oral Antidiabetic Drugs Sales Price (USD/MT)
Figure China 2016 Oral Antidiabetic Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Oral Antidiabetic Drugs 2012-2017E
Figure Europe 2012-2017E Oral Antidiabetic Drugs Sales Price (USD/MT)
Figure Europe 2016 Oral Antidiabetic Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Oral Antidiabetic Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Oral Antidiabetic Drugs Sales Price (USD/MT)
Figure Southeast Asia 2016 Oral Antidiabetic Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Oral Antidiabetic Drugs 2012-2017E
Figure Japan 2012-2017E Oral Antidiabetic Drugs Sales Price (USD/MT)
Figure Japan 2016 Oral Antidiabetic Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Oral Antidiabetic Drugs 2012-2017E
Figure India 2012-2017E Oral Antidiabetic Drugs Sales Price (USD/MT)
Figure India 2016 Oral Antidiabetic Drugs Sales Market Share
Table Global 2012-2017E Oral Antidiabetic Drugs Sales (K MT) by Type
Table Different Types Oral Antidiabetic Drugs Product Interview Price
Table Global 2012-2017E Oral Antidiabetic Drugs Sales (K MT) by Application
Table Different Application Oral Antidiabetic Drugs Product Interview Price
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly Oral Antidiabetic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Eli Lilly Oral Antidiabetic Drugs Business Region Distribution
Table Abbott Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Oral Antidiabetic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Abbott Oral Antidiabetic Drugs Business Region Distribution
Table Biocon Information List
Table Product A Overview
Table Product B Overview
Table 2015 Biocon Oral Antidiabetic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Biocon Oral Antidiabetic Drugs Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Oral Antidiabetic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Sanofi Oral Antidiabetic Drugs Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Oral Antidiabetic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Merck Oral Antidiabetic Drugs Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Oral Antidiabetic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Pfizer Oral Antidiabetic Drugs Business Region Distribution
Table Sunpharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sunpharma Oral Antidiabetic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Sunpharma Oral Antidiabetic Drugs Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Oral Antidiabetic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Novartis Oral Antidiabetic Drugs Business Region Distribution
Table Novo Nordisk Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novo Nordisk Oral Antidiabetic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Novo Nordisk Oral Antidiabetic Drugs Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2016 Boehringer Ingelheim Oral Antidiabetic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Boehringer Ingelheim Oral Antidiabetic Drugs Business Region Distribution
Table Oramed Pharmaceuticals Information List
Table Takeda Pharmaceuticals Information List
Table Jiangsu Wanbang Information List
Table Nanjing Xinbai Information List
Figure Global 2017-2022 Oral Antidiabetic Drugs Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 Oral Antidiabetic Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Oral Antidiabetic Drugs Sales Price (USD/MT) Forecast
Figure North America 2017-2022 Oral Antidiabetic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 Oral Antidiabetic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 Oral Antidiabetic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Oral Antidiabetic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 Oral Antidiabetic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 Oral Antidiabetic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Oral Antidiabetic Drugs by Type 2017-2022
Table Global Consumption Volume (K MT) of Oral Antidiabetic Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Oral Antidiabetic Drugs by Region

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *